Date: July 30, 2026
ESOP Allotment Details
Gland Pharma Limited's ESOP Compensation Committee, in its meeting held on July 30, 2026, allotted 6,979 equity shares of Re. 1/- each to 8 employees upon exercise of their stock options under the Gland Pharma Employee Stock Options Scheme, 2025.
Share Capital Impact
Consequently, the issued, subscribed and paid-up share capital of the Company increased to ₹164,966,661 comprising 164,966,661 equity shares of face value Re. 1/- each.
Specific Allotment Information
- Date of Allotment: July 30, 2026
- Number of Shares Allotted: 6,979 equity shares
- Distinctive Numbers: 16,49,59,683 to 16,49,66,661 (both inclusive)
- Par Value: Rs. 1/- per share
- Security Type: Equity Shares
- Scheme: Gland Pharma Employee Stock Option Scheme 2025
- Stock Exchange Filing Dates: BSE & NSE - May 03, 2025
- Filing Numbers: BSE – 231155; NSE – 48425
- Shares are identical in all respects to existing shares and rank pari passu
- No lock-in period applies to the allotted shares